HR8375

1) On April 20, 2026, Rep. John Joyce (R-PA) introduced HR8375, the 'Medicare Advantage Improvement Act of 2026', with six cosponsors including a mix of Republicans and Democrats. The bill was referred to both the Ways and Means and Energy and Commerce Committees. On April 27, the sponsor delivered introductory remarks on the House floor. The bill is in early stage — no committee hearings, markups, or Senate companion bill yet. 2) The bill does not authorize or appropriate any funding — it imposes an operational mandate. It amends section 1852(g)(1) of the Social Security Act to require MA plans to respond to standard prior authorization requests within 72 hours (extendable by up to 7 days if the enrollee requests it or if additional medical evidence is needed). The effective date is January 1, 2028, giving insurers 20 months from enactment to comply. No penalties are specified in the introduced text, but CMS typically enforces through compliance actions and potential civil money penalties. 3) All five publicly traded MA insurers — UNH, HUM, CVS (Aetna), CNC, MOH — are directly obligated. The bill is net-neutral to slightly bearish for pure-play MA insurers (HUM) due to higher compliance costs as a percentage of revenue, neutral for diversified insurers with vertical integration (UNH via Optum, CVS via Caremark/Oak Street), and procedurally neutral for CNC and MOH given smaller MA exposure. The compliance burden primarily affects administrative operations, not benefit design or premium setting, limiting revenue impact. 4) Real market data shows a powerful rally across MA insurers over the 30 days preceding this bill: UNH +36%, HUM +37%, CNC +63%, MOH +47%, CVS +16%. This rally was driven by the April 2026 Medicare Advantage final rate notice (not provided here) which included favorable payment updates. The bill's introduction on April 20 occurred during this rally (UNH closed $323.48 that day vs $368.37 on April 30). The market has not penalized insurers post-introduction; instead, stocks continued rising, suggesting the bill is viewed as a manageable administrative reform rather than a fundamental threat to MA profitability. 5) Timeline: The bill must pass through two House committees (Ways and Means, Energy and Commerce), then a full House vote, then the Senate (no companion bill yet), then reconciliation, then presidential signature. The 2028 effective date suggests Congress anticipates a multi-year legislative process. Passage odds are moderate (~35%) given bipartisan cosponsorship but early procedural stage. If enacted, the primary market impact will be seen in 2027-2028 as insurers invest in compliance systems.